Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Apr 1;139(4):698-717.
doi: 10.1097/AOG.0000000000004730.

Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2

ACOG Committee on Clinical Practice Guidelines–Gynecology
Collaborators
Practice Guideline

Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2

ACOG Committee on Clinical Practice Guidelines–Gynecology. Obstet Gynecol. .

Erratum in

Abstract

Purpose: To provide updated evidence-based recommendations for the treatment of postmenopausal osteoporosis.

Target population: Postmenopausal patients with primary osteoporosis.

Methods: This guideline was developed using an a priori protocol in conjunction with a writing team consisting of two specialists in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Guidelines-Gynecology and one external subject matter expert. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements.

Recommendations: This Clinical Practice Guideline includes updated recommendations on who should receive osteoporosis pharmacotherapy, the benefits and risks of available pharmacotherapy options, treatment monitoring and follow-up, and the role of calcium and vitamin D in the management of postmenopausal osteoporosis. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence.

PubMed Disclaimer

Comment in

References

    1. Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, et al. Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review. Ann Intern Med 2019;171:37–50. doi: 10.7326/M19-0533 - DOI
    1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465–75. doi: 10.1359/jbmr.061113 - DOI
    1. Osteoporosis prevention, screening, and diagnosis. Clinical Practice Guideline No. 1. American College of Obstetricians and Gynecologists. Obstet Gynecol 2021;138:494–506. doi: 10.1097/AOG.0000000000004514 - DOI
    1. Clinical practice guideline methodology: methodology. American College of Obstetricians and Gynecologists. Obstet Gynecol 2021;138:518–22. doi: 10.1097/AOG.0000000000004519 - DOI
    1. United Nations Development Programme. Human Development Reports: Human Development Index (HDI). Accessed December 7, 2021. http://hdr.undp.org/en/content/human-development-index-hdi

Publication types

Substances